FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

CareFusion Recalls Alaris Pump Module

Becton Dickinsons CareFusion unit recalls its Alaris Patient Controlled Analgesia infusion pump module 8120 because the compatible syringes labeling c...

latest-news-card-1
Human Drugs

Dont Approve Amryts Filsuvez NDA: Petition

A Lassman Law petition filed for an unidentified client asks FDA not to approve an Amryt NDA for Filsuvez to treat cutaneous manifestations of junctio...

latest-news-card-1
Federal Register

Compliance Delay on Cosmetic Registration

Federal Register notice: FDA makes available a guidance entitled Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Lis...

latest-news-card-1
Human Drugs

Former Reviewer McGarry Joins Greenleaf Health

Former FDA reviewer Sarah McGarry joins consulting firm Greenleaf Health as senior vice president of drug and biological products.

latest-news-card-1
Marketing

Rexulti Ads False and Misleading: OPDP

The CDER Office of Prescription Drug Promotion says two Otsuka Rexulti ads contain misleading presentations of the drugs efficacy.

latest-news-card-1
Human Drugs

14 Observations in Kilitch India FDA-483

FDA releases the form FDA-483 with 14 observations from an inspection at the Kilitch Healthcare India sterile drug manufacturing facility in Maharasht...

latest-news-card-1
Federal Register

FDA Proposes to Withdraw Carbadox Approval

Federal Register notice: FDA proposes to withdraw approval of Phibro Animal Healths NADAs for carbadox in medicated swine feed.

latest-news-card-1
Biologics

Improve Cell, Gene Manufacturing Guidance: ISCT

The International Society for Cell & Gene Therapy suggests ways to improve an FDA draft guidance on manufacturing changes and comparability for human ...

latest-news-card-1
Human Drugs

FTC Challenges Patent Listings in Orange Book

In a major move against questionable drug patents, the FTC challenges the legitimacy of more than 100 patents listed in FDAs Orange Book.

latest-news-card-1
Human Drugs

Law Blog Faults FDA on Remote Evaluations

Two Hyman, Phelps & McNamara staff say FDA missed an opportunity to conduct many remote interactive evaluations of drug manufacturing sites.